NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Clinical trials for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder cancer cocktail aims to spare patients from surgery
Disease control Not yet recruitingThis phase 2 trial tests whether a drug called N-803, combined with either BCG or gemcitabine, can treat intermediate-risk bladder cancer without needing surgery. About 20 adults with low-grade papillary tumors will receive the drugs directly into the bladder. The main goal is to…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Microscopic clues may forecast bladder Cancer's next move
Knowledge-focused Not yet recruitingThis study examines two microscopic details in bladder cancer tumors—how deep early cancer cells have invaded and whether small clusters of cells are present at the tumor's edge. Researchers will look at tissue samples from 100 patients to see if these features can predict if the…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC